CN102186969A - 由人多能干细胞制备人皮肤替代品的方法 - Google Patents
由人多能干细胞制备人皮肤替代品的方法 Download PDFInfo
- Publication number
- CN102186969A CN102186969A CN2009801256559A CN200980125655A CN102186969A CN 102186969 A CN102186969 A CN 102186969A CN 2009801256559 A CN2009801256559 A CN 2009801256559A CN 200980125655 A CN200980125655 A CN 200980125655A CN 102186969 A CN102186969 A CN 102186969A
- Authority
- CN
- China
- Prior art keywords
- human
- cells
- stem cells
- pluripotent stem
- keratinocyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0629—Keratinocytes; Whole skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/10—Hair or skin implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Virology (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08305320.7 | 2008-06-25 | ||
| EP08305320 | 2008-06-25 | ||
| EP08305447 | 2008-08-04 | ||
| EP08305447.8 | 2008-08-04 | ||
| US9095708P | 2008-08-22 | 2008-08-22 | |
| US61/090,957 | 2008-08-22 | ||
| EP09305077 | 2009-01-28 | ||
| EP09305077.1 | 2009-01-28 | ||
| PCT/EP2009/057817 WO2009156398A1 (en) | 2008-06-25 | 2009-06-23 | Methods for preparing human skin substitutes from human pluripotent stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102186969A true CN102186969A (zh) | 2011-09-14 |
Family
ID=40863382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009801256559A Pending CN102186969A (zh) | 2008-06-25 | 2009-06-23 | 由人多能干细胞制备人皮肤替代品的方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110165130A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2297299A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2011525370A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20110022713A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102186969A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009264336A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0914422A2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009156398A1 (cg-RX-API-DMAC7.html) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104789521A (zh) * | 2014-01-22 | 2015-07-22 | 广州康睿生物医药科技有限公司 | 一种晶状体上皮干细胞的分离培养方法 |
| CN106754652A (zh) * | 2017-03-06 | 2017-05-31 | 广州润虹医药科技有限公司 | iPS细胞分化成外胚层祖细胞的无血清诱导培养基及诱导方法 |
| CN106834214A (zh) * | 2017-03-27 | 2017-06-13 | 广州润虹医药科技有限公司 | 一种诱导多能干细胞形成角质形成细胞的诱导培养基及诱导方法 |
| CN107849530A (zh) * | 2015-06-22 | 2018-03-27 | 新加坡国立大学 | 血管化组织、皮肤或黏膜等效物 |
| CN107988147A (zh) * | 2017-12-19 | 2018-05-04 | 江汉大学 | 基于器官芯片与诱导多能干细胞的定向分化用于3d拟表皮构建的方法 |
| CN108367099A (zh) * | 2015-10-21 | 2018-08-03 | 印第安纳大学研究与技术公司 | 来自多能干细胞的人皮肤类器官的衍生 |
| CN110093306A (zh) * | 2018-01-31 | 2019-08-06 | 中山大学 | 人工毛囊及其制备方法和应用 |
| CN112941015A (zh) * | 2021-03-19 | 2021-06-11 | 上海爱萨尔生物科技有限公司 | 一种基于多能干细胞分化制备角质细胞的添加剂及方法 |
| CN112980775A (zh) * | 2021-03-19 | 2021-06-18 | 上海爱萨尔生物科技有限公司 | 一种基于多能干细胞分化制备角质细胞的培养液 |
| CN113046300A (zh) * | 2021-03-19 | 2021-06-29 | 上海爱萨尔生物科技有限公司 | 一种基于多能干细胞分化制备角质细胞的培养方法 |
| US12077778B2 (en) | 2015-10-21 | 2024-09-03 | Indiana University Research And Technology Corporation | Methods of generating human inner ear sensory epithelia and sensory neurons |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120142103A1 (en) * | 2009-05-18 | 2012-06-07 | Kohji Nishida | Method for inducing differentiation into epithelial progenitor cell/stem cell population and corneal epithelial cell population from induced pluripotent stem cells |
| US8529883B2 (en) * | 2010-05-07 | 2013-09-10 | Fibrocell Technologies, Inc. | Dosage unit formulations of autologous dermal fibroblasts |
| RU2458983C1 (ru) * | 2011-07-18 | 2012-08-20 | Российская Федерация, От Имени Которой Выступает Министерство Образования И Науки Российской Федерации | Способ получения индуцированных плюрипотентных стволовых клеток из фибробластов пациентов с болезнью хангингтона |
| US20160237400A1 (en) * | 2013-03-15 | 2016-08-18 | The Jackson Laboratory | Isolation of non-embryonic stem cells and uses thereof |
| TW201522637A (zh) * | 2013-03-15 | 2015-06-16 | Jackson Lab | 非胚胎幹細胞之單離及其用途 |
| US9545302B2 (en) | 2013-11-20 | 2017-01-17 | Dermagenesis Llc | Skin printing and auto-grafting |
| KR102354410B1 (ko) * | 2014-02-21 | 2022-01-21 | 다이니뽄 스미토모 세이야쿠 가부시키가이샤 | 눈 질환 치료제, 이의 스크리닝 방법, 및 망막 색소 상피 세포 이식과 연관된 거부 반응의 예측 방법 |
| US20180230436A1 (en) * | 2014-10-10 | 2018-08-16 | Garrett VYGANTAS | Methods of manufacturing keratin products and uses thereof |
| JP6736253B2 (ja) * | 2014-12-22 | 2020-08-05 | ザ チャイニーズ ユニバーシティ オブ ホンコン | 体細胞から多能性幹細胞を作製するための機械的操作とプログラミンの併用 |
| US10167451B2 (en) | 2014-12-22 | 2019-01-01 | The Chinese University Of Hong Kong | Combinational use of mechanical manipulation and programin derivatives to increase Oct4, Sox2, or Nanog expression in fibroblasts |
| US10273549B2 (en) | 2016-04-21 | 2019-04-30 | Vitrolabs Inc. | Engineered skin equivalent, method of manufacture thereof and products derived therefrom |
| WO2018107064A1 (en) * | 2016-12-09 | 2018-06-14 | The University Of Chicago | Tissue organoids |
| WO2019004533A1 (ko) * | 2017-06-30 | 2019-01-03 | 주식회사 스템랩 | 소변세포로부터 케라티노사이트 줄기세포로의 직접 역분화 방법 및 역분화된 케라티노사이트 줄기세포를 이용한 피부재생 촉진용 조성물의 제조방법 |
| EP3875580A1 (en) | 2020-03-02 | 2021-09-08 | Centre d'Etude des Cellules Souches (CECS) | Methods for preparing keratinocytes |
| EP3875581A1 (en) * | 2020-03-02 | 2021-09-08 | Centre d'Etude des Cellules Souches (CECS) | Automated method for preparing keratinocytes |
| EP3875124A1 (fr) | 2020-03-02 | 2021-09-08 | Urgo Recherche Innovation Et Developpement | Procede d'obtention d'un tissu dermo-epidermique pre-vascularise |
| JP7315184B2 (ja) * | 2022-02-16 | 2023-07-26 | 株式会社コーセー | 多能性幹細胞から表皮角化細胞への分化誘導方法 |
| WO2026004911A1 (ja) * | 2024-06-26 | 2026-01-02 | 国立大学法人東京科学大学 | 皮膚オルガノイド、移植シート及び全層構成皮膚組織、並びにそれらの製造方法 |
| EP4726028A1 (en) * | 2024-10-11 | 2026-04-15 | Evonik Operations GmbH | Reconstructed skin model |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2825370A1 (fr) * | 2001-05-31 | 2002-12-06 | Inst Nat Sante Rech Med | Keratinocytes obtenus a partir de cellules souches embryonnaires de mammiferes |
-
2009
- 2009-06-23 US US12/999,129 patent/US20110165130A1/en not_active Abandoned
- 2009-06-23 WO PCT/EP2009/057817 patent/WO2009156398A1/en not_active Ceased
- 2009-06-23 JP JP2011515354A patent/JP2011525370A/ja active Pending
- 2009-06-23 BR BRPI0914422A patent/BRPI0914422A2/pt not_active IP Right Cessation
- 2009-06-23 CN CN2009801256559A patent/CN102186969A/zh active Pending
- 2009-06-23 EP EP09769247A patent/EP2297299A1/en not_active Withdrawn
- 2009-06-23 AU AU2009264336A patent/AU2009264336A1/en not_active Abandoned
- 2009-06-23 KR KR1020117001947A patent/KR20110022713A/ko not_active Withdrawn
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104789521B (zh) * | 2014-01-22 | 2017-11-07 | 广州康睿生物医药科技股份有限公司 | 一种晶状体上皮干细胞的分离培养方法 |
| CN104789521A (zh) * | 2014-01-22 | 2015-07-22 | 广州康睿生物医药科技有限公司 | 一种晶状体上皮干细胞的分离培养方法 |
| CN107849530A (zh) * | 2015-06-22 | 2018-03-27 | 新加坡国立大学 | 血管化组织、皮肤或黏膜等效物 |
| CN108367099A (zh) * | 2015-10-21 | 2018-08-03 | 印第安纳大学研究与技术公司 | 来自多能干细胞的人皮肤类器官的衍生 |
| US12077778B2 (en) | 2015-10-21 | 2024-09-03 | Indiana University Research And Technology Corporation | Methods of generating human inner ear sensory epithelia and sensory neurons |
| CN108367099B (zh) * | 2015-10-21 | 2021-11-23 | 印第安纳大学研究与技术公司 | 来自多能干细胞的人皮肤类器官的衍生 |
| CN106754652A (zh) * | 2017-03-06 | 2017-05-31 | 广州润虹医药科技有限公司 | iPS细胞分化成外胚层祖细胞的无血清诱导培养基及诱导方法 |
| CN106754652B (zh) * | 2017-03-06 | 2019-04-02 | 广州润虹医药科技股份有限公司 | iPS细胞分化成外胚层祖细胞的无血清诱导培养基及诱导方法 |
| CN106834214A (zh) * | 2017-03-27 | 2017-06-13 | 广州润虹医药科技有限公司 | 一种诱导多能干细胞形成角质形成细胞的诱导培养基及诱导方法 |
| CN106834214B (zh) * | 2017-03-27 | 2020-02-14 | 广州润虹医药科技股份有限公司 | 一种诱导多能干细胞形成角质形成细胞的诱导培养基及诱导方法 |
| CN107988147B (zh) * | 2017-12-19 | 2021-11-09 | 江汉大学 | 基于器官芯片与诱导多能干细胞的定向分化用于3d拟表皮构建的方法 |
| CN107988147A (zh) * | 2017-12-19 | 2018-05-04 | 江汉大学 | 基于器官芯片与诱导多能干细胞的定向分化用于3d拟表皮构建的方法 |
| CN110093306A (zh) * | 2018-01-31 | 2019-08-06 | 中山大学 | 人工毛囊及其制备方法和应用 |
| CN110093306B (zh) * | 2018-01-31 | 2022-12-02 | 中山大学 | 人工毛囊及其制备方法和应用 |
| CN113046300A (zh) * | 2021-03-19 | 2021-06-29 | 上海爱萨尔生物科技有限公司 | 一种基于多能干细胞分化制备角质细胞的培养方法 |
| CN112980775A (zh) * | 2021-03-19 | 2021-06-18 | 上海爱萨尔生物科技有限公司 | 一种基于多能干细胞分化制备角质细胞的培养液 |
| CN112980775B (zh) * | 2021-03-19 | 2024-01-23 | 上海爱萨尔生物科技有限公司 | 一种基于多能干细胞分化制备角质细胞的培养液 |
| CN112941015A (zh) * | 2021-03-19 | 2021-06-11 | 上海爱萨尔生物科技有限公司 | 一种基于多能干细胞分化制备角质细胞的添加剂及方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011525370A (ja) | 2011-09-22 |
| KR20110022713A (ko) | 2011-03-07 |
| US20110165130A1 (en) | 2011-07-07 |
| BRPI0914422A2 (pt) | 2017-03-21 |
| WO2009156398A1 (en) | 2009-12-30 |
| AU2009264336A1 (en) | 2009-12-30 |
| EP2297299A1 (en) | 2011-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20110165130A1 (en) | Methods for Preparing Human Skin Substitutes from Human Pluripotent Stem Cells | |
| Tsuchiyama et al. | Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts | |
| US20190367883A1 (en) | Regulating stem cells | |
| JP2011525370A5 (cg-RX-API-DMAC7.html) | ||
| Aberdam | Derivation of keratinocyte progenitor cells and skin formation from embryonic stem cells | |
| EP2539438A1 (en) | Methods for preparing human melanocytes from human pluripotent stem cells | |
| CN106661547B (zh) | 调控毛发生长的方法和组合物 | |
| US7186558B2 (en) | Keratinocytes obtained from embryonic stem cells of mammals | |
| JP2006506063A (ja) | 毛髪誘導細胞の培養 | |
| Ganjibakhsh et al. | Three-dimensional decellularized amnion membrane scaffold promotes the efficiency of male germ cells generation from human induced pluripotent stem cells | |
| Ji et al. | Generation and differentiation of human embryonic stem cell-derived keratinocyte precursors | |
| JP2015097524A (ja) | 再構成皮膚の作製用の組成物および方法 | |
| JP2016516394A (ja) | ヒト線維芽細胞において特徴的な幹細胞であるMuse細胞から容易に分化した機能性メラノサイトの使用 | |
| WO2009080794A1 (en) | Method for preparing cell-specific extracellular matrices | |
| Heng et al. | Directing stem cells into the keratinocyte lineage in vitro | |
| Yonetani et al. | In vitro expansion of immature melanoblasts and their ability to repopulate melanocyte stem cells in the hair follicle | |
| KR101760239B1 (ko) | 세포배양 삽입체를 이용한 인간 배아줄기세포 유래 중간엽 세포의 분리방법 | |
| Kinebuchi et al. | Direct induction of layered tissues from mouse embryonic stem cells: potential for differentiation into urinary tract tissue | |
| EP4114921B1 (en) | Methods for preparing keratinocytes | |
| Dong et al. | Enrichment of epidermal stem cells by rapid adherence and analysis of the reciprocal interaction of epidermal stem cells with neighboring cells using an organotypic system | |
| Sah et al. | Human induced pluripotent stem cell–derived keratinocyte progenitors | |
| A Rahman | The development of in vitro models of human salivary glands | |
| Dezawa et al. | Regenerating Melanocytes: Current Stem Cell Approaches with Focus on Muse Cells | |
| Shamis | hESC-and iPSC-Derived Fibroblasts for Skin Engineering and Repair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110914 |